Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
CVS Health Corporation logo

NASDAQ · CVS

CVS Health Corporation

Healthcare · Medical - Healthcare Plans

$90.25

Down-$0.08 (-0.09%)

Updated Oct 31, 2026, 7:54 PM

SID Score

6.1/10

Composite research score

Smart Money

58/100

Neutral

Market cap
102.62B
P/E ratio
218.73
Dividend yield
2.95%
52-week range
$69.51 – $110.68
Volume
8.19M
Avg. volume
7.37M

Price performance · CVS

CVS price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 30, 2026

CVS closed at $90.25 after 21 trading sessions, up 4.38% for the selected period.

Last close
$90.25
Period change
+4.38%
Period low
$86.16
Period high
$94.75
Daily close
View OHLC price history
CVS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 30, 2026$91.95$91.95$89.9014$90.258.19M
Oct 29, 2026$91.85$91.90$89.55$90.3310.23M
Oct 28, 2026$90.58$91.5299$89.89$89.955.58M
Oct 27, 2026$92.52$93.065$90.95$91.134.59M
Oct 26, 2026$93.65$94.77$92.035$92.534.26M
Oct 23, 2026$94.00$94.40$93.215$93.474.6M
Oct 22, 2026$93.08$94.835$92.49$94.487.23M
Oct 21, 2026$95.26$95.26$93.42$93.456.53M
Oct 20, 2026$93.255$94.905$93.202$94.757.07M
Oct 19, 2026$91.60$92.74$91.03$92.685.38M
Oct 16, 2026$93.24$93.345$92.05$92.366.98M
Oct 15, 2026$91.78$92.64$91.00$92.5814.27M
Oct 14, 2026$88.10$90.78$88.10$90.399.33M
Oct 13, 2026$89.20$89.89$86.125$87.5510.48M
Oct 12, 2026$86.60$87.98$86.045$87.7411.57M
Oct 9, 2026$85.90$88.86$85.80$86.1611.65M
Oct 8, 2026$87.86$88.50$86.82$87.807.83M
Oct 7, 2026$87.05$89.93$87.00$87.958.47M
Oct 6, 2026$86.80$87.08$85.525$86.4311.04M
Oct 5, 2026$86.69$87.51$86.3322$87.0112.01M
Oct 2, 2026$85.25$87.15$85.25$86.4610.46M

Latest CVS news

The latest Smart Investors Daily articles mentioning CVS.

Stock researchCompany · Overview

CVS research

Overview

Company profile and research snapshot.

Company profile

CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$94.91
Implied upside
—
Analysts
17
CVS recent ratings
DateFirmRatingTarget
Oct 12, 2026Leerink PartnersOutperform—
Sep 3, 2026UBSBuy—
Aug 19, 2026Argus ResearchBuy—
Aug 12, 2026JP MorganOverweight—
Aug 6, 2026Evercore ISI GroupOutperform—
Open full forecast

News briefing

Generated Oct 31, 2026, 5:04 PM

Why Is CVS Moving Slightly Lower Today?

CVS Health is down marginally today as investors digest mixed signals ahead of Q3 earnings, with valuation opportunities emerging alongside regulatory headwinds. The stock's slight decline reflects the market's cautious stance as the company faces both analyst optimism about undervaluation and new transparency pressures from the Trump administration targeting drug middlemen practices.

    Bottom line: CVS presents a classic value trap-versus-value opportunity dynamic, trading at a significant discount while facing regulatory pressures that could reshape PBM economics. Investors should await Q3 earnings for clarity on management's response to transparency rules and revised guidance, while acknowledging the stock's long-term appeal for patient, dividend-focused portfolios willing to weather near-term regulatory uncertainty.

    Yahoo · Oct 31, 2026

    CVS Health (CVS) Could Be 27% Undervalued As Earnings Focus Sharpens

    CVS Health stock reacts to upcoming earnings focus CVS Health (CVS) heads into its next earnings report with Wall Street expecting quarterly earnings of $1.62 per share, placing fresh attention on how each business segment is contributing. Recent headlines around CVS Health's community housing projects and medication safety initiatives have landed against a mixed backdrop. The share price is US$90.25 after a 30-day share price return of 5.32% but a 90-day share price decline of 13.58%. At the...

    Yahoo · Oct 30, 2026

    1 value stock to own for decades and 2 we ignore

    Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason, and a low valuation can reflect underlying business challenges rather than a genuine bargain.

    Yahoo · Oct 30, 2026

    CVS Health: How Education and Everyday Action Can Support Medication Safety

    Key points * Red Ribbon Week is a timely opportunity for adults to begin age-appropriate conversations about medication safety, substance misuse and mental health. * Dose of Knowledge provides free lessons and interactive resources for students in grades K-12, educators, caregivers and communities.

    AI research layers

    Interpretive context generated from the platform’s current data sources.

    No results

    AI research layers have not been published yet.

    Featured By